Jong M. Rho, MD, is a senior staff scientist at the Barrow Neurological Institute and St. Joseph's Hospital & Medical Center in Phoenix, Arizona. After obtaining an undergraduate degree in molecular biophysics and biochemistry at Yale University, Dr. Rho received his medical degree from the University of Cincinnati. Following a pediatric residency at the University of Southern California Children's Hospital of Los Angeles and a neurology residency at the University of California, Los Angeles (UCLA), School of Medicine, he completed fellowships in pediatric neurology at the UCLA School of Medicine and in neuropharmacology at the National Institutes of Health (NIH). Dr. Rho's main research interests are the mechanisms underlying the anticonvulsant and neuroprotective effects of the ketogenic diet, neuropharmacology of anticonvulsant compounds, and the study of surgically respected human epileptic tissue. His research activities have been sponsored by several NIH research grants, as well as a variety of intramural and extramural public and private sector sources. Dr. Rho has served on the editorial boards of Epilepsia and Epilepsy Currents and has been a regular reviewer for research grants submitted to the NIH. In addition to an extensive list of publications in basic science and pediatric neurology peer-reviewed journals, Dr. Rho has written numerous book chapters and edited several books and is a popular national and international guest lecturer. Raman Sankar, MD, PhD, is a professor of neurology and pediatrics and chief of pediatric neurology at the David Geffen School of Medicine at UCLA. He holds the Rubin Brown Distinguished Chair in Pediatric Neurology. Dr. Sankar obtained his doctorate from the University of Washington in medicinal chemistry and was involved in teaching and research for several years prior to entering Tulane Medical School, where he obtained his medical degree. He trained in p

"In summary, I strongly congratulate the editors and authors for producing a book that accomplishes its task of refocusing epilepsy research on its primary directive, translation of scientific discoveries into interventions and methods that directly relate and promise to improve the quality of medical care our patients with seizures receive. Although not exhaustive enough, it will be an invaluable primer for young investigators but also for more senior researchers who aim to create new bridges with aspects of epilepsy research that are more distant from their immediate focus." -Aristea S. Galanopoulou, Albert Einstein College of Medicine, Epilepsy & Behavior, 2011 Praise for the First Edition "... a much-needed textbook. It attempts to integrate data regarding the most relevant developments in research with those regarding clinical issues that have a direct effect on therapeutics. The book achieves this goal by reviewing current therapies and discussing new areas of research and treatment. Much of what is discussed provides a good review for not only the epilepsy community but also for general neurologists. ...Perhaps the most exciting discussion in the book concerns the future of epilepsy research and treatment. ...Although such goals may have seemed far-reaching a decade ago, the findings and ideas presented here make the concept of antiepileptogenesis appear to be an attainable goal." -Teresa Tran, M.D., MINCEP Epilepsy Care, Minneapolis, Minnesota, USA, in New England Journal of Medicine, February 2005

• Scientific Foundations. Antiepileptic Drugs. Epilepsy Surgery. Alternative Therapies. Other Modulators of the Epileptic State. The Future of Epilepsy Therapy.